Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
On January 13, 2023, the China National Intellectual Property Administration ("CNIPA") published the Draft Revision of the China Trademark Law ("Draft Revision"). Compared with previous revisions to
A report on the patent index regarding the Guangdong-Hong Kong-Macao Greater Bay Area was released at a forum held on Saturday in South China's Guangdong province. The report on the patent index was
the Anti-monopoly Compliance Guidelines for Operators in Hebei Province in accordance with theAnti-monopoly Law(“AML”) of the People’s Republic of China. [3] Shenzhen BOC Issues Shenzhen Implementation
%. Recently, the Ministry of Commerce of China released the development of trade in services in the first half of the year 2023, according to the latest statistics, China's knowledge-intense service
patent filings in the pharmaceutical space for Q2 and July 2023 using information from GlobalData patent analytics database. Top on the list is authorities in China, handing out almost five times the
In recent years, as China’s economy and technology have continued to develop, there has been an increasing demand for a trade and technology-related IPR protection system. The IPR protection system
Although China is generally not the first choice for NPE (Non-Practicing Entity) to initiate litigation, when facing global litigation strategies against a particular company, the Chinese market is
The rapid development of generative artificial intelligence has raised concerns about the necessity of legal governance, and China has recently become one of the first jurisdictions to do so.
Patenting Medical Use Inventions in China A medical use of a product may relate to i) the use of a new drug to treat a disease (“first medical use”); ii) the use of a known drug to treat a new
On June 29, 2023, China’s State Administration for Market Regulation (SAMR) released the amended Provisions on Prohibiting the Abuse of Intellectual Property Rights to Exclude or Restrict
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
